两个d~(10)金属配位聚合物的合成、结构及对2,4,6-三硝基苯酚的选择性检测（英文）

以4,4′-二(1-咪唑基)苯硫醚(BIDPT),4,4′-羧基二苯胺(H2aba),5-氧乙酸间苯二酸(H_3OABDC),Zn(NO_3)_2·6H_2O和Cd(NO_3)_2·6H_2O为原料,用溶剂热法合成了2个配位聚合物[Zn(BIDPT)(aba)]n(1)和[Cd(BIDPT)(HOABDC)]n(2)。利用X射线单晶衍射、红外、元素分析、热重分析和X射线粉末衍射对其进行了表征。单晶X射线衍射研究发现配合物1为具有二重穿插的三维dia拓扑网络结构;配合物2为3-连接六边形的hcb二维拓扑结构,再通过氢键堆积作用形成三维超分子结构。1和2具有很好的荧光性质,硝基苯化合物对配合物1和2的荧光性质有不同程度的淬灭作用。它们都对2,4,6-三硝基苯酚的检测具有很好的灵敏性。对其淬灭机理进行了深入的研究。     

沙漏型砷钼酸盐(NH_4)_7[AsMo_8O_(30)]的水热合成,结构和性质(英文)

利用水热合成法制备了一种新的沙漏型砷钼酸盐化合物(NH_1)_7[AsMo_8O_(30)](1),借助X射线单晶衍射、X射线粉末衍射、红外光谱(IR)、紫外光谱(UV)和热分析研究了化合物的结构和性质.结果表明,化合物1属于正交晶系,Cmcm空间群,晶胞参数为:a=0.848 3(4)nm,b=2.322 3(10)nm,c=1.559 1(7)nm,V=3.071(2)nm~3,Z=4,R_1[I>2σ(I)]=0.0431,ωR_2[I>2σ(I)]=0.123 6.X射线单晶衍射分析结果表明,化合物1包含沙漏型的砷钼酸盐阴离子[AsMo_9O_(30)]~(7-).     

超分子化合物[H3N(CH2)3NH3]•[Pb2(SIP)2]•6H2O的水热合成与表征

在水热条件下, 用NaH2SIP与Pb(Ⅱ)盐, 以1,3-丙二胺(1,3-PDA)作为结构导向剂进行反应, 得到化合物[H3N(CH2)3NH3]•[Pb2(SIP)2]•6H2O(1). 同时采用单晶X射线衍射、X射线粉末衍射、元素分析、红外光谱和荧光光谱对化合物1进行了表征.     

新颖四核镍夹心的杂化锗钨酸盐的合成、结构与表征

在水热条件下合成了一个新颖的夹心结构四核镍有机-无机杂化锗钨酸盐[Ni(dien)(H2O)3]2·[Ni(Hdien)2]{[Ni(dien)]2Ni4(H2O)2(GeW9O34)2}·10H2O(1), 利用X射线单晶衍射确定了其结构, 并通过红外光谱、热重、X射线粉末衍射、X射线能谱和元素分析对其进行了表征. 其晶体属三斜晶系, P1, a=1.1937(3) nm, b=1.4323(3) nm, c=1.6394(4) nm, α=93.424(2)°, β=96.058(3)°, γ=109.758(4)°, V=2.6094(1) nm3,Z=1. X射线单晶衍射结果表明, 化合物1是由夹心构型的多阴离子通过镍-二乙烯三胺配阳离子连接形成的一维线性结构.     

类蝎型铜配合物的合成、结构及光谱特征

在四氢呋喃体系中合成了一个具有平面结构的三齿吡唑-三嗪(类蝎型)化合物2,4-二(3,5-二甲基吡唑)-6-二乙基胺-1,3,5-三嗪(简称bpz*eaT), 并以其为配体, 在无水乙醇溶剂中合成了2个新配合物₂·(CuCl₄)(1)和Cu_1.5Cl₃(bpz*eaT)(2). 通过元素分析、红外光谱、紫外光谱、荧光光谱、热重分析、X射线粉末衍射以及X射线单晶衍射等方法对配合物进行了表征, 分析了其光谱及结构特征. 结构分析表明, bpz*eaT采取三齿螯合配位模式, 配合物1和2中的铜均为五配位, 形成了扭曲的四角锥构型. 采用密度泛函理论(DFT)中的B3LYP方法研究了这2个配合物的稳定性和电荷分布.     

超分子化合物[UO2Cl4][phenH]2的合成、晶体结构、荧光性质及[UO2Cl4][phenH]2/PVA薄膜的发光性能

水热条件下合成了一种含铀的超分子化合物[UO2Cl4][phenH]2(phen=1,10-邻菲罗啉),进行了X射线单晶衍射、红外光谱、紫外光谱和荧光光谱分析。 晶体结构分析表明,该化合物由2个[phenH]+阳离子和1个阴离子[UO2Cl4]2-组成。 红外光谱和X射线单晶衍射表明,标题化合物的三维框架是由N-H…Cl、C-H…Cl和C-H…O弱氢键相互作用所构建。 中心U原子是六配位,有4个Cl原子和2个O原子。 此外,没参与配位的phen利用氢键和π…π堆积与[UO2Cl4]2-相互作用。 含U原子的阴离子是一种扭曲八面体结构。 利用溶胶-凝胶法合成了化合物的PVA薄膜。 标题化合物和薄膜均有较强的荧光性。CCDC:713149     

基于2,6-二(4-羧基苯亚甲基)环己酮的金属-有机框架化合物的合成与表征

以2,6-二(4-羧基苯亚甲基)环己酮(H2L)为配体得到一例锰金属-有机框架化合物[MnL]n,并运用红外、热重、循环伏安、固体紫外、X射线光电子能谱和X射线单晶衍射对其进行表征.单晶衍射分析表明该配合物属于三斜晶系,空间群P(1),不对称单元由Mn(Ⅱ)离子和一个L2-配体组成.配体两端的羧基均为单齿配位,配体中间...     

(TAGH)2(TNR)的合成、晶体结构及热分析

合成了三氨基胍三硝基间苯二酚盐(TAGH)2(TNR) (TAG: 三氨基胍; TNR: 2,4,6-三硝基间苯二酚), 并对其进行了元素分析及红外光谱表征. 利用X射线单晶衍射分析测定了其晶体结构. 该晶体属于单斜晶系, 空间群为C2/c, 晶体学数据为, a=2.2892(6) nm, b=1.2802(3) nm, c=1.3661(4) nm, β=111.174(5)°, V=3.7333(16) nm3, Z=8. 该化合物是由二个C(N2H3)+3与一个(C6HN3O8)2-相结合而成的离子型化合物. 用差示扫描量热法、热重法和微商热重法研究了该化合物的热分解过程, 研究结果表明, 在10 K·min-1的升温速率下, 该化合物只有一个剧烈的放热分解过程, 该过程发生在450.1-477.7 K之间, 且分解产物主要是气体产物.     

新型共晶配合物[Co(1,10-phen)2(AcO)]·H2SDA·11H2O的合成、晶体结构及性质

采用溶剂热法,以4,4′-二苯乙烯二羧酸,1,10-邻菲罗啉和乙酸钴为原料,构筑了一个新型共晶钴配合物[Co(1,10-phen)₂(AcO)]·H₂SDA·11H₂O（CCDC: 1983364, 1,10-phen=1,10-邻菲罗啉,H₂SDA=4,4′-二苯乙烯二羧酸）,其结构和性质经FL, IR,元素分析,TGA和X-射线单晶衍射表征。结果表明：配合物属三斜晶系,P_ī空间群。配合物是由一个单核钴配合物以及一个H₂SDA 分子构成的共晶配合物,其中单核钴配合物中的Co(II)分别与乙酸根中的两个氧原子以及两个1,10-邻菲罗啉配体中的4个氮原子配位,形成了一个六配位的CoN₄O₂八面体构型。共晶化合物分子间通过O-H…O氢键形成二维结构,再经π…π堆积作用形成三维空间构型。配合物在低浓度条件下表现出荧光性质,并存在荧光浓度自猝灭效应。     

β-二亚胺基Ni(Ⅱ)配合物的合成及其催化乙烯聚合研究

合成了一系列带有不同取代基的β-二亚胺配体及其Ni(Ⅱ)的配合物.利用核磁共振谱、元素分析和单晶X射线衍射等手段对配体及配合物进行了表征.元素分析和单晶结构分析表明,在相同的实验条件下苯基取代的β-二亚胺配体锂盐与NiCl2反应只能得到双配体化合物1;而2,6-二甲基苯基及2,6-二异丙基苯基取代的配体锂盐与NiCl2反应得二聚的单氯化物2和3,2个Ni原子通过双氯桥连接在一起.配合物2和3经烷基铝活化后催化乙烯聚合可得到高分子量聚乙烯,活性可达到2.0×105gPE/(molcat·h),分子量最高可达到100万以上.     

Mechanism of sodium chloride diossolving in water and the process of the solution aging

By the method of Flicker Noise Spectroscopy (FNS) we studied the process of sodium chloride dissolving in water (3.5 wt %) at 294 K on the level of long-range order formation in liquid. It is established that the process of dissolving the salt includes the following steps: formation of instable colloid particles, instable solvate clusters of the salt ion pairs (iSCIP), instable dissolved polymers of globular type, and 12 h later beginning of a new process of formation stable solvate clusters of the salt ion pairs (sSCIP) and stable polymer globules on their basis. Stroke diagrams of the cluster nano-structure and a model of aging the salt solution are presented. Influence of atmospheric pressure on the SCIP average weight is demonstrated. It is concluded that on the SCIP surface there is a porous layer of solvate water with membrane properties. The cluster structure of the 3.5 wt % solution prepared by dissolving the salt is shown to differ from that of the solution obtained by dilution. The solutions long-range order is formed by the nano dispersion of the water solvated salt crystal nuclei. The mechanism of the solution aging is discussed.     

Spectroscopic Characterization of Carbazole-TCAQ Charge-Transfer Salt

Spectroscopic characterizations of carbazole-TCAQ salt were investigated by means of UV-visible and fluorescence spectra. The results show that carbazole and TCAQ can form a kind of charge-transfer salt whose characteristic adsorption is π→π^* of 248 nm when the mixture of the two compounds is irradiated by UV-light, and the charge-transfer salt becomes more stable with the increase of irradiation time.     

双甲基化大豆苷元磺酸盐的合成、晶体结构及活性研究

以大豆苷元为原料合成了强水溶性异黄酮类化合物7,4′-二甲氧基异黄酮-3′-磺酸钠(1)和7,4′-二甲氧基异黄酮-3′-磺酸铜(2).X射线单晶衍射分析表明,化合物1的分子组成为[Na(H₂O)₂](C₁₇H₁₃O₄SO₃),Na的配位数为6,且相邻钠离子以7,4′-二甲氧基异黄酮-3′-磺酸根氧原子桥连,与两个磺酸根的3个氧原子和1个S原子组成六元环,六元环通过Na-O配位键彼此稠合,在晶体结构中形成延伸的锯齿状聚合八面体配位钠离子链;这些钠离子链之间又通过配位水与配位水、磺酸根之间的氢键作用自组装成二维结构的超分子离子聚合物.化合物2的分子组成为[Cu(H₂O)₆](C₁₇H₁₃O₄SO₃)₂·8H₂O,Cu(Ⅱ)位于对称中心上.[Cu(H₂O)₆]²⁺,C₁₇H₁₃O₄SO^-₃和H₂O之间存在多种氢键;并且异黄酮环反平行排列存在π…π的堆积作用.氢键和π…π的堆积作用使化合物2自组装成三维结构的超分子.抗缺氧缺血活性试验结果表明,它们的抗缺氧缺血活性比大豆苷元的高.     

(Solid + liquid) phase diagram for (indomethacin + nicotinamide)-methanol or methanol/ethyl acetate mixture and solubility behavior of 1:1 (indomethacin + nicotinamide) co-crystal at T = (298.15 and 313.15) K

(Solid + liquid) equilibrium data for indomethacin (IMC) and nicotinamide (NCT) in both methanol (MeOH) and methanol/ethyl acetate (EA) mixture were determined using a static method at T = (298.15 and 313.15) K under atmospheric pressure. The 1:1 (IMC + NCT) co-crystal and IMC·MeOH were found in both systems under conditions investigated. The solubility of the 1:1 (IMC + NCT) co-crystal was correlated using a mathematical model consisting of both solubility product and a complexation process. Solubility of (IMC + NCT) co-crystals as a function of co-former (NCT) concentration was evaluated. It was found that temperature has a significant effect on the formation of methanol solvate in the systems investigated. Solvate formation could be suppressed either by increasing temperature or using solvent mixtures. Additionally, the solvent mixture could level out the solubility differences between IMC and NCT, resulting in larger and more symmetric regions for the (IMC + NCT) co-crystal, which would be helpful to the development of the co-crystallization process for the 1:1 (IMC + NCT) co-crystal.     

尖吻蝮蛇毒抗凝血因子Ⅱ的稀土离子荧光探针研究

尖吻蝮蛇毒抗凝血因子(ACF)分子中有两个钙离子结合位点,钙离子对ACF的内源荧光有增强作用,稀土离子(Nd³⁺,Sm³⁺,Eu³⁺,Gd³⁺和Tb³⁺)能取代ACF分子中的钙离子,并对ACF的内源荧光有不同程度的猝灭作用,其中Tb³⁺接受ACF分子中Trp残基传递的能量后,特征荧光增强.稀土离子与ACF荧光滴定表明,ACF分子中有两个稀土离子结合位点,稀土离子和钙离子在ACF分子中两个结合部位是共同的竞争结合部位.ACF与不同稀土离子之间有相近的表观结合常数K₁或K₂.Tb³⁺与RE³⁺(RE=Nd,Sm,Eu或Gd)间线性自由能关系表明,稀土离子与ACF结合时,没有明显的空间效应.ACF分子中的两个结合位点在结构上都有较大的柔性,这种结构柔性为钙离子在ACF与活化凝血因子X的结合反应中起到的促进作用提供了结构基础.     

Syntheses,Structures, and Properties of Five Coordination Polymers Involving Phthalic Acid

Five new coordination polymers Cu(phen)(H2O)(phth)·CH3OH(1), [Cu(2,2'-bipy)(H2O)](phth)·3.5H2O(2), Zn(phen)(phth)(H2O)·1.125H2O(3) and [M(4,4'-bipy)(H2O)2](phth)·2H2O[M=Zn(4), Mn(5)](H2phth=phthalic acid, bipy=bipyridine, phen=1,10-phenanthroline) have been synthesized from the amino acid derivatives(phthalyl-l- valine, H2L) and structurally characterized. H2L was hydrolyzed into phth2– group during the reaction, but the strucure feature was different from that of the complex directly synthesized from H2phth in the reported literature, revealing that H2L played an important role in composing the novel compounds. Compounds 1, 2 and 3 are all 1D chains, but the differences are that compound 1 is further hydrogen-bonded into 2D networks, and compound 2 is further extended into 3D supramolecular network through π-π stacking and hydrogen-bonding interactions. However, compound 3 is a 1D helix chain structure and further links into 2D networks through π-π stacking. Compounds 4 and 5 are isostructural and exhibit the same 2D layers, which are further connected by hydrogen-bonding interactions to form 3D supramolecular network. Antiferromagnetic superexchange was observed for compounds 1, 2 and 5.     

Structural Study on Four co-Crystals of N-Containing Heteroaromatics with Iodofluorobenzene

N-Containing heteroaromatics 1,2,4,5-tetra(pyridin-3-yl)benzene[1,2,4,5-T(3-PY)B] and 1,2,4,5-tetra-(pyridin-4-yl)benzene[1,2,4,5-T(4-PY)B] were each co-crystallized with 1,2-diiodo-tetrafluoro-benzene(1,2-DITFB), or 1,4-diiodo-tetrafluoro-benzene(1,4-DITFB), respectively, generating four co-crystals, namely, (1,2-DITFB)₄·[1,2,4,5-T(3-PY)B](1), (1,2-DITFB)₄·[1,2,4,5-T(4-PY)B](2), (1,4-DITFB)₂·[1,2,4,5-T(3-PY)B]·CHCl₃(3), and (1,4-DITFB)·[1,2,4,5-T(4-PY)B]·2CHCl₃(4). This study takes aim at providing an insight into the relative importance of fundamental solid state halogen bonding interactions(i.e., halogen…N, halogen…halogen, and halogen…π) in systems. The effects of the donor and acceptor on supramolecular assembly and the crystal structure determined interactions were discussed. The N…I halogen bonds are the main directing interactions responsible for the observed structures. In compounds 1 and 2, the donors exhibited lower-than-expected supramolecular connectivity. In spite of this, co-crystal 2 exhibits polymeric structures consisting of infinite one-dimensional(1D) double-zigzag chains of alternating electron donor and acceptor. The basic structure of co-crystals 3 and 4 is also infinite 1D chain. Therefore, the 1D halogen bonded supramolecular assemblies can be obtained by matching the appropriate donor and acceptor.     

Synthesis,Structure and Properties of Two New Coordination Polymers Based on 4-[（8-Hydroxy-5-quinolinyl）azo]-benzenesulfonic Acid

Two new coordination polymers based on 4-[（8-hydroxy-5-quinolinyl）azo]-benzenesulfonic acid（H2L）,{[CdL（H2O）2]·H2O}n（1） and {[CdL（en）]·EtOH}n（2）（en=ethylenediamine）,were solvothermally synthesized and structurally characterized by single-crystal X-ray diffraction.Compounds 1 and 2 exhibit infinite 1D ladder-shaped chain structures,which are isostructural except that the two coordinating water molecules in compound 1 were replaced by one en molecule in compound 2 due to the use of different organic base.Compounds 1 and 2 were constructed into different supramolecular frameworks by hydrogen bonding and π…π stacking interactions.In addition,the fluorescent properties of compounds 1 and 2 were investigated.Furthermore,they were also investigated via IR spectral analysis,elemental analysis,powder X-ray diffraction（PXRD） and thermogravimetric analysis（TGA）.     

Solid state of a new flavonoid derivative DA-6034

DA-6034 is a new synthetic flavonoid known to possess anti-inflammatory activity. The objective of this work was to investigate the existence of polymorphs and pseudopolymorphs of DA-6034. Six crystal forms, one hydrate form and five solvates, of DA-6034 have been isolated by recrystallization and characterized by differential scanning calorimetry (DSC), thermogravimetric analysis (TG), and powder X-ray diffractometry (PXRD). From the DSC and TG data it was confirmed that Form 1 is monohydrate; Form 2 is DMSO solvate; Form 3 is 1/2 DMSO solvate; Form 4 is 1/2 methyl ethyl ketone solvate; Form 5 is 1.5 H₂O, 1/2 acetic acid solvate; Form 6 is 1/2 H₂O, 1/4 butanol solvate. The PXRD patterns of the six crystal forms were different respectively. In the dissolution studies in pH 6.8 ± 0.05 buffer at 37 ± 0.5 °C, the solubility of solvates was higher than that of Form 1.     

Dihydrofolate Reductase Inhibitors: The Pharmacophore as a Guide for Co-Crystal Screening

In this work, co-crystal screening was carried out for two important dihydrofolate reductase (DHFR) inhibitors, trimethoprim (TMP) and pyrimethamine (PMA), and for 2,4-diaminopyrimidine (DAP), which is the pharmacophore of these active pharmaceutical ingredients (API). The isomeric pyridinecarboxamides and two xanthines, theophylline (THEO) and caffeine (CAF), were used as co-formers in the same experimental conditions, in order to evaluate the potential for the pharmacophore to be used as a guide in the screening process. In silico co-crystal screening was carried out using BIOVIA COSMOquick and experimental screening was performed by mechanochemistry and supported by (solid + liquid) binary phase diagrams, infrared spectroscopy (FTIR) and X-ray powder diffraction (XRPD). The in silico prediction of low propensities for DAP, TMP and PMA to co-crystallize with pyridinecarboxamides was confirmed: a successful outcome was only observed for DAP + nicotinamide. Successful synthesis of multicomponent solid forms was achieved for all three target molecules with theophylline, with DAP co-crystals revealing a greater variety of stoichiometries. The crystalline structures of a (1:2) TMP:THEO co-crystal and of a (1:2:1) DAP:THEO:ethyl acetate solvate were solved. This work demonstrated the possible use of the pharmacophore of DHFR inhibitors as a guide for co-crystal screening, recognizing some similar trends in the outcome of association in the solid state and in the molecular aggregation in the co-crystals, characterized by the same supramolecular synthons.